The Nekicesa team travelled to Paris on February 1 and 2 to exhibit in Pharmapack, where they presented their technological innovations regarding the implementation of serialized codes and anti-counterfeit measures for cases.

The pharmaceutical sector is undergoing an almost imminent reconversion and adaptation because of the amendment of Directive 2011/62, which induces the whole European system to regulate and guarantee traceability of medicines along the entire production and distribution chain.

Pharmapack is the ideal venue to establish the objectives of this year and start configuring the verification system among the players involved in the distribution and manufacture of medicines.

More than 387 exhibitors and around 5,144 attendees were present during these two intense days, where Nekicesa had the opportunity to interact with several areas of the pharma industry, mostly from Europe.